a Correlation of MDSCs with TFR/TFH cells in peripheral blood of HCV patients. The frequencies of MDSC (CD14+CD33+HLA-DR−), TFR (CD4+CXCR5+Foxp3+) and TFH (CD4+CXCR5+Foxp3−) cells in PBMCs of 9 HCV-infected patients were simultaneously examined by flow cytometry, and then analyzed by Pearson Correlation. R and P values are shown above the summary data. b CD33+ myeloid cells from HCV patients induce TFR cell generation. Healthy PBMCs were co-cultured with or without CD33+ myeloid cells derived from HCV patients for 5 days, followed by flow cytometric analysis for the percentage of TFR cell (CD4+CXCR5+Foxp3+) frequency in lymphocytes. c Reducing TFR cells, but not TFH cells, by depletion of CD33+ myeloid cells from PBMCs derived from HCV patients. HCV-derived PBMCs, with or without MDSC depletion, were cultured in vitro for 5 days, followed by flow analysis for CD4+CXCR5+Foxp3+ TFR and CD4+CXCR5+Foxp3− TFH cells. d Representative dot plots and summary data of flow cytometric analysis of IFN-γ production by CD4+ cells in PBMCs with or without CD33+ myeloid cell depletion. e Depletion of CD33+ myeloid cells from PBMCs of HCV patients improves IFN-γ production by T follicular cells, TFR and TFH cells. HCV PBMCs, with or without CD33+ myeloid cell depletion, were cultured ex vivo in the presence of stimulation for 5 days, followed by immune staining and flow analysis for IFN-γ production by CD4+CXCR5+ T follicular cells as well as CD4+CXCR5+Foxp3+ TFR and CD4+CXCR5+Foxp3− TFH cells. f Depletion of CD33+ myeloid cells from PBMCs of HCV patients reduces IL-10 production by T follicular cells and TFR cells, but not by TFH cells. PBMCs isolated from chronic HCV patients, with or without depletion of CD33+ myeloid cells, were cultured ex vivo in the presence of anti-CD3/CD28 stimulation, followed by flow cytometric analysis for IL-10 expression in CD4+CXCR5+ T cells as well as CD4+CXCR5+Foxp3+TFR and CD4+CXCR5+Foxp3− TFH cells. P values are shown above each panel